Rebecca Wurm‐Kuczera

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

University Hospital Münster(Current)

Paracelsus Medical University

Heinrich Heine University Düsseldorf

Charité - Universitätsmedizin Berlin

Düsseldorf University Hospital

Rebecca Wurm‐Kuczera is an author at University Hospital Münster specializing in immuno-oncology pharmacotherapy, relapsed diffuse large b-cell lymphoma, and cytokine-based therapy.

Publications per year

2023–2025

Publications

Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma

Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib et al. · Blood Advances · 2025 · 28 citations · Full text

Life Sciences, Immunology, Oncology +16

Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study

Evgenii Shumilov, Rebecca Wurm‐Kuczera, Andrea Kerkhoff et al. · Blood Advances · 2024 · 24 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14

<i>Feasibility and Safety of the First-in-Human Chemotherapy-Light Combination of Rituximab, Polatuzumab Vedotin and Glofitamab in Previously Untreated Aggressive B-Cell Lymphoma Patients Above 60 Years of Age Ineligible for a Fully Dosed R-CHOP - R-Pola-Glo/Ikf-t062, a Study of the Austrian Group for Medical Tumor Therapy (AGMT-NHL-16) and the German Lymphoma Alliance (GLA2022-10)</i>

Thomas Melchardt, Rebecca Wurm‐Kuczera, Bettina Altmann et al. · Blood · 2023 · 11 citations

Medicine, Oncology, Pharmacotherapy +17

1–3 of 3